Artificial Intelligence in Medicine Campus Conference

Funding Opportunities

Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)

Agency: NIH

Description: This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand the role of social connectedness and/or loneliness in prevention, treatment and recovery from substance use disorders (SUDs). Research may use a variety of approaches, including leveraging existing data sources, survey research, social network analysis, new methods development, feasibility research, etc. Outcomes of interest include any of the following: substance use initiation, escalation, SUD diagnosis, connection to treatment, and engagement or retention in treatment or recovery.

Announcement Number: RFA-DA-23-009

Closing Date: August 15, 2022

Link to Full Announcement

HRSA - Public Health Scholarship Program

(HRSA-22-122)

Agency: Health Resources and Services Administration

Description: The purpose of PHSP is to strengthen the public health workforce by providing support to organizations to develop scholarship programs that incentivize individuals to pursue training and careers in public health. Through the PHSP, scholarship recipients will gain the requisite knowledge and skills necessary to prevent, prepare for, and respond to recovery activities related to COVID–19, as well as other public health emergencies. Awarded recipients will provide scholarships to individuals, for the purpose of public health training in professional, graduate, degree, and/or certificate programs. Scholarship recipients will be trained to work as case investigators, contact tracers, social support specialists, public health nurses, disease intervention specialists, epidemiologists, program managers, laboratory personnel, informaticians, communication and policy experts, and any other positions as may be required to prevent, prepare for, and respond to recovery activities related to COVID-19, as well as other public health emergencies.

Period of Performance is September 30, 2022 through September 29, 2025 (3 years). You may apply for a ceiling amount of up to $1,500,000 per award (fully-funded at the outset for the use over the period of performance), with a ceiling amount of $500,000 per year (includes both direct and indirect/facilities and administrative costs).

Closing Date: June 1, 2022

Link to Funding Announcement

Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities

Issued by National Institute of Environmental Health Sciences (NIEHS)

Purpose: The purpose of this supplement is to provide support for successful applicants to develop partnerships with local worker centers and community organizations specifically targeting underserved and disadvantaged communities with higher than average COVID-19 transmission rates.

Related Announcements

PA-20-135 - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).

NOT-ES-21-002 - Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities

Link to Full Announcement

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Epidemiologic Studies of Diabetes Incidence and Severity and Its Potential Association with COVID-19

Issued by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose: NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for epidemiologic studies of diabetes incidence and severity and its potential association with coronavirus disease 2019 (COVID-19) and the causative virus SARS-CoV-2.

Research Objectives: Conduct an epidemiologic study of diabetes incidence and severity at onset and its potential association with COVID-19 and the causative virus SARS-CoV-2 among children and/or adults with appropriate comparison group(s) that takes into consideration other potential risk factors for the increase in diabetes incidence.

Budget: NIDDK intends to make multiple awards based on this urgent competitive revision. The total budget for these epidemiologic studies is $3 million. Application budgets are limited to the current year direct cost budget, or $350,000 direct costs (whichever is less), exclusive of consortium FA costs. Budgets must reflect the actual needs of the proposed project.

Applications will be accepted until June 1, 2022, by 5:00 PM local time of the applicant organization. This NOSI expires on June 2, 2022. An application submitted in response to this NOSI that is received on/after the expiration date will be withdrawn.

Link to Full Announcement

Submit Content for the Next Research Newsletter!